Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis

Keiji Yokoyama, Ryo Yamauchi, Kumiko Shibata, Hiromi Fukuda, Hideo Kunimoto, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka

Clin Mol Hepatol. 2019;25(2):183-189. Published online November 9, 2018

DOI: https://doi.org/10.3350/cmh.2018.0039

View: 6266 Download: 137 Web of Science: 10 Crossref: 11

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach

Sang Jung Park, Yong Kwon Kim, Yeon Seok Seo, Seung Woon Park, Han Ah Lee, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jae Young Jang, Jong Eun Yeon, Kwan Soo Byun

Clin Mol Hepatol. 2016;22(4):487-494. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0050

View: 8805 Download: 150 Web of Science: 10 Crossref: 9

3

Endoscopic Sedation in Developing and Developed Countries

Ariel A. Benson , Lawrence B. Cohen , Jerome D. Waye , Alaleh Akhavan , James Aisenberg

Clin Mol Hepatol. 2008;12(2):105-112.

View: 2159 Download: 12

1 |

Viewed By 5169	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5028	MAFLD: How is it different from NAFLD?
Viewed By 4973	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3647	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3604	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search